There is no relationship between Paraoxonase serum level activity in women with endometriosis and the stage of the disease: An observational study

Reproductive Health

Volumn 10, Issue 1, 2013, Pages

  Bragatto, Felipe Barca ^a   Barbosa, Caio Parente ^a   Christofolini, Denise Maria ^a   Peluso, Carla ^a   Dos Santos, Aline Amaro ^a   Mafra, Fernanda Abani ^a   Cavalcanti, Viviane ^a   Hix, Sonia ^a   Bianco, Bianca ^a  

^a FACULDADE DE MEDICINA DO ABC   (Brazil)

Author keywords

Endometriosis; High density lipoprotein; Infertility; Oxidative stress; Paraoxonase

Indexed keywords

ARYLDIALKYLPHOSPHATASE; GLUCOSE;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; ENDOMETRIOSIS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; SPECTROPHOTOMETRY;

ADULT; ARYLDIALKYLPHOSPHATASE; ENDOMETRIOSIS; FEMALE; HUMANS; INFERTILITY, FEMALE; OXIDATIVE STRESS;

EID: 84879113887     PISSN: None     EISSN: 17424755     Source Type: Journal    
DOI: 10.1186/1742-4755-10-32     Document Type: Article

References (49)

1. Frequency of endometriotic lesions in peritoneum samples from asymptomatic fertile women and correlation with CA125 values. Barbosa CP, Souza AM, Bianco B, Christofolini D, Mafra FA, Lima GR, Sao Paulo Med J 2009 127 342 345 10.1590/S1516-31802009000600004 20512287
2. The effects of hormones on endometriosis development. Barbosa CP, Souza AM, Bianco B, Christofolini D, Minerva Ginecol 2011 63 375 386 21747346
3. OC-125 Immunostaining in endometriotic lesion samples. Barbosa CP, de Souza AM, Bianco B, Christofolini D, Mafra FA, Lima GR, Arch Gynecol Obstet 2010 281 43 47 10.1007/s00404-009-1055-7 19363680
4. Serum markers of oxidative stress in infertile women with endometriosis. De Andrade AZ, Rodrigues JK, Dib LA, Romão GS, Ferriani RA, Junior AAJ, Navarro PAAS, Rev Bras Ginecol Obstet 2010 32 279 285 20945013
5. Quantitative and qualitative peritoneal imune profiles. Cabrera JM, Zamudio LJ, Latorre EG, Orozco OC, Guerrero CH, T-cell apoptosis and oxidative stress-associated characteristics in women with minimal and mild endometriosis. BJOG 2011 118 6 16
6. The vitamin E-binding protein afamin is altered significantly in the peritoneal fluid of women with endometriosis. Seeber BE, Czech T, Buchner H, Barnhart KT, Seger C, Daxenbichler G, Wildt L, Dieplinger H, Fertil Steril 2010 94 2923 2926 10.1016/j.fertnstert.2010.05.008 20858448
7. Mechanistic and Therapeutic Implications of Angiogenesis in Endometriosis. Taylor RN, Yu J, Torres PB, Schickedanz AC, Park JK, Mueller MD, Sidell N, Reprod Sci 2009 16 140 146 10.1177/1933719108324893 19001553
8. Role of oxidative stress in endometriosis. Gupta S, Agarwal A, Krajcir N, Alvarez JG, Reprod Biomed Online 2006 13 126 134 10.1016/S1472-6483(10)62026-3 16820124 (Pubitemid 44054856)
9. Role of oxidative stress in female reproduction. Agarwal A, Gupta S, Sharma RK, Reprod Biol Endocrinol 2005 3 28 10.1186/1477-7827-3-28 16018814 (Pubitemid 41522097)
10. Serum paraoxonase-1 activity in women with endometriosis and its relationship with the stage of the disease. Verit FF, Erel O, Celik N, Hum Reprod 2008 23 100 104 18000171 (Pubitemid 351767315)
11. Paraoxonase1-192 polymorphism modulates the effects of regular and acute exercise on paraoxonase1 activity. Tomás M, Elosua R, Sentí M, Molina L, Vila J, Anglada R, et al. J Lipid Research 2002 43 713 720 (Pubitemid 34477898)
12. Pharmacogenetics of paraoxonases: a brief review, Naunyn-Schmiedeberg's Arch. Draganov DI, La Du BN, Pharmacol 2002 369 78 88 (Pubitemid 38161225)
13. On the physiological role(s) of the paraoxonases. La Du BN, Aviram M, Billecke S, Navab M, Primo-Parmo S, Sorenson RC, Standiford TJ, Chem Biol Interact 1999 119-120 379 388 23131608 (Pubitemid 29278574)
14. Structure-Reactivity Studies of Serum Paraoxonase PON1 Suggest that Its Native Activity Is Lactonase. Khersonsky O, Tawfik DS, Biochemistry 2005 44 6371 6382 10.1021/bi047440d 15835926 (Pubitemid 40570731)
15. Selective plasma hydrolysis of glucocorticoid gammalactones and cyclic carbonates by the enzyme paraoxonase: an ideal plasma inactivation mechanism. Biggadike K, Angell RM, Burgess CM, Farrell RM, Hancock AP, Harker AJ, Irving WR, Ioannou C, Procopiou PA, Shaw RE, Solanke YE, Singh OM, Snowden MA, Stubbs RJ, Walton S, Weston HE, J Med Chem 2000 43 19 21 10.1021/jm990436t 10633034 (Pubitemid 30055759)
16. Structural modifications of HDL and functional consequences. Ferretti G, Bacchetti T, Nègre-Salvayre A, Salvayre R, Dousset N, Curatola G, Atherosclerosis 2006 184 1 7 10.1016/j.atherosclerosis.2005.08.008 16157342 (Pubitemid 41721062)
17. The paraoxonases: role in human diseases and methodological difficulties in measurement. Camps J, Marsillach J, Joven J, Crit Rev Clin Lab Sci 2009 46 83 106 10.1080/10408360802610878 19255916
18. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice. Rozenberg O, Rosenblat M, Coleman R, Shih DM, Aviram M, Free Radic Biol Med 2003 34 774 778 10.1016/S0891-5849(02)01429-6 12633754 (Pubitemid 36288542)
19. Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice. Rozemberg O, Shih DM, Aviram M, Atherosclerosis 2005 181 9 18 10.1016/j.atherosclerosis.2004.12.030 15939049 (Pubitemid 40804688)
20. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Aviram M, Rosenblat M, Free Radical Biol Med 2004 9 1304 1316 (Pubitemid 39349234)
21. Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females. Ferretti G, Bacchetti T, Moroni C, Savino S, Liuzzi A, Balzola F, Bicchiega V, J Clin Endocrinol Metab 2005 3 1728 1733 (Pubitemid 40464045)
22. Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine. Rosenblat M, Vaya J, Shih DM, Aviram M, Atherosclerosis 2005 179 69 77 10.1016/j.atherosclerosis.2004.10. 028 15721011 (Pubitemid 40249787)
23. The human paraoxonase gene cluster as a target in the treatment of atherosclerosis. She M, Chen H, Yan Y, Li H, Liu D, Antioxid Redox Signal 2012 16 597 632 10.1089/ars.2010.3774 21867409
24. Paraoxonase and arylesterase activities in coronary artery disease. Gur M, Aslan M, Yildiz A, Demirbag R, Yilmaz R, Selek S, Erel O, Ozdogru I, Eur J Clin Invest 2006 36 779 787 10.1111/j.1365-2362.2006.01727.x 17032345 (Pubitemid 44569966)
25. Immunohistochemical analysis of paraoxonases-1 and 3 in human atheromatous plaques. Marsillach J, Camps J, Beltran-Debón R, Rull A, Aragones G, Maestre-Martínez C, Sabench F, Hernández M, Castillo DD, Joven J, Mackness M, Mackness B, Eur J Clin Invest 2011 41 308 314 10.1111/j.1365-2362.2010.02411.x 20964682
26. Revised American Society for Reproductive Medicine classification of endometriosis. Fertil Steril 1997 67 817 821 10.1016/S0015-0282(97)81391-X 9130884 (Pubitemid 27183908)
27. Minitab 16 Statistical Software Windows. State College, PA: Minitab, Inc. 2010 http://www.minitab.com
28. The relationships of leptin, adiponectin levels and paraoxonase activity with metabolic and cardiovascular risk factors in females treated with psychiatric drugs. Ozenoglu A, Balci H, Ugurlu S, Caglar E, Uzun H, Sarkis C, Gunay C, E, EE, Clinics (Sao Paulo) 2008 63 651 660 10.1590/S1807- 59322008000500014
29. Racial Differences in Paraoxonase-1 (PON1): A Factor in the Health of Southerners? Davis K, Crow J, Chambers H, Meek E, Chambers J, Environ Health Perspect 2009 117 1226 1238 19672401
30. Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus. Ikeda Y, Suehiro T, Inoue M, Nakauchi Y, Morita T, Arii K, Metabolism 1998 47 598 602 10.1016/S0026-0495(98)90246-3 9591753 (Pubitemid 28213122)
31. Serum paraoxonase activity in uremic predialysis and hemodialysis patients. Dirican M, Akca R, Darandol E, Dilek K, J Nephrol 2004 17 813 818 15593056 (Pubitemid 41158301)
32. Paraoxonase and arylesterase activities in coronary artery disease. Gur M, Aslan M, Yildiz A, Demirbag R, Eur J Clin Invest 2006 36 779 787 10.1111/j.1365-2362.2006.01727.x 17032345 (Pubitemid 44569966)
33. HDL capacity to inhibit LDL oxidation in well-trained triathletes. Brites F, Zago V, Verona J, Muzzio ML, Wikinski R, Schreier L, Life Sci 2006 78 3074 3081 10.1016/j.lfs.2005.12.015 16488445
34. Atherosclerosis in women with endometriosis. Pretta S, Remorgida V, Abbamonte LH, Anserini P, Ragni N, Del Sette M, Gandolfo C, Ferrero S, Eur J Obstet Gynecol Reprod Biol 2007 132 226 231 10.1016/j.ejogrb.2006.04.015 16682112 (Pubitemid 46817705)
35. Unfavorable lipid profile in women with endometriosis. Melo A, Rosa-e-Silva C, Rosa-e-Silva A, Poli-Neto O, Ferriani R, Vieira C, Fertil Steril 2010 93 2433 2436 10.1016/j.fertnstert.2009.08.043 19969295
36. Role of reactive oxygen species in the pathophysiology of human reproduction. Agarwal A, Saleh RA, Bedaiwy MA, Fertil Steril 2003 79 829 843 10.1016/S0015-0282(02)04948-8 12749418 (Pubitemid 36385000)
37. Oxidative stress may be a piece in the endometriosis puzzle. Szczepanska M, Kozlik J, Skrzypczak J, Mikolajczyk M, Fertil Steril 2003 79 1288 1293 10.1016/S0015-0282(03)00266-8 12798872 (Pubitemid 36687873)
38. Role of oxidative stress in endometriosis. Gupta S, Krajcir N, Alvarez JG, Agarwal, Reprod Biomed Online 2006 13 126 134 10.1016/S1472-6483(10)62026-3 16820124 (Pubitemid 44054856)
39. Pathogenic mechanisms in endometriosis-associated infertility. Gupta S, Goldberg JM, Aziz N, Goldberg E, Krajcir N, Agarwal A, Fertil Steril 2008 90 247 257 10.1016/j.fertnstert.2008.02.093 18672121 (Pubitemid 352040722)
40. Serum markers of oxidative stress in infertile women with endometriosis. Andrade AZ, Rodrigues JK, Dib LA, Romão GS, Ferriani RA, Jordão Junior AA, Navarro PA, Rev Bras Ginecol Obstet 2010 32 279 285 20945013
41. The role of the oxidative-stress in the endometriosis-related infertility. Augoulea A, Mastorakos G, Lambrinoudaki I, Christodoulakos G, Creatsas G, Gynecol Endocrinol 2009 25 75 81 10.1080/09513590802485012 19253102
42. Female infertility and free 11. radicals: potential role in adhesions and endometriosis. Alpay Z, Saed GM, Diamond MP, J Soc Gynecol Investig 2006 13 390 398 10.1016/j.jsgi.2006.05.002 16872846 (Pubitemid 46059277)
43. Antioxidants. Rebelatto JR, Jiménez R, Delgado MA, Muguerza B, Muñoz ME, Galan AI, Sánchez RM, Arenillas JIC, Physical Activity and Oxidative Stress in Older Women. Rev Bras Med Esporte 2008 14 8 11
44. Interethnic variability of plasma paraoxonase (PON1) activity towards organophosphates and PON1 polymorphisms among Asian populations-a short review. Mohamed A, Chia S, Ind Health 2008 46 309 317 10.2486/indhealth.46.309 18716378
45. Uncu. Serum Paraoxonase and Arylesterase Activities Throughout normal pregnancy. Sarandöl E, Dirican M, Eröz E, Kirhan E, Serdar Z, Nobel Medicus 2010 19 49 55
46. Human tissue distribution of paraoxonases 1 and 2 mRNA. Mackness B, Beltran-Debon R, Aragones G, Joven J, Camps J, Mackness M, IUBMB Life 2010 62 480 482 20503442
47. PPARs in Regulation of Paraoxonases: Control of Oxidative Stress and Inflammation Pathways. Camps J, García-Heredia A, Rull A, Alonso-Villaverde C, Aragonès G, Beltrán-Debón R, Rodríguez-Gallego E, Joven J, PPAR Res 2012 2012 616371 22315585
48. HDL-associated paraoxonase-1 can redistribute to cell membranes and influence sensitivity to oxidative stress. Deakin S, Bioletto S, Bochaton-Piallat M, James R, Free Radic Biol Med 2011 1 102 109
49. The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity. James R, Deakin S, Free Radic Biol Med 2004 15 1986 1994 (Pubitemid 39491318)